Abstract
Parkinson’s disease (PD) is a neurodegenerative disease that is accompanied with the loss of dopaminergic neurons in the substantia nigra pars compacta which subsequently leads to a reduction in the dopamine level in the striatum. The flavonoids are gaining critical attention in the management of PD due to the toxic effects of the synthetic drugs. Naringin, a potent flavonoid, exerts neuroprotective activity against experimental animal models of PD. It also exhibits protective activity against rotenone-induced neurotoxicity in cell line studies. Therefore, the present study was designed to evaluate the therapeutic potential of naringin against rotenone-induced animal model of PD. The rotenone was injected through intracerebroventricular route into substantia nigra pars compacta (SNpc) to induce PD-like manifestations in the male rats. The behavioral deficits of the animals due to dopaminergic toxicity were evaluated in actophotometer, OFT, bar catalepsy, narrow beam walk, rota-rod, grip strength and foot print analysis. Naringin-attenuated rotenone-induced behavioral abnormalities in the experimental rats. Further, naringin reduced the rotenone-induced dopaminergic toxicity in striatum and SNpc the animals. At the sub-cellular level, naringin attenuated the rotenone-induced decrease in the mitochondrial function, integrity and bioenergetics in the SNpc of the animals. Furthermore, naringin reduced the rotenone-induced mitochondria-dependent apoptosis in the rat SNpc. However, Trigonelline significantly abolished the therapeutic effects of naringin on behavioral, biochemical and molecular observations in rotenone-induced PD-like animals. These observations indicate that naringin may exert neuroprotective activity against rotenone-induced toxicity in the animals possibly through Nrf2-mediated pathway. Thus, it can be presumed that naringin could be an alternative option in the management of PD.
Similar content being viewed by others
References
Anusha, C., Sumathi, T., & Joseph, L. D. (2017). Protective role of apigenin on rotenone induced rat model of Parkinson's disease: Suppression of neuroinflammation and oxidative stress mediated apoptosis. Chemico-Biological Interactions,269, 67–79.
Bradford, M. M. (1976). A rapid and sensitive method for the quantitation of microgram quantities of protein utilizing the principle of protein-dye binding. Analytical Biochemistry,72, 248–254.
Burke, R. E., & O’Malley, K. (2013). Axon degeneration in Parkinson’s disease. Experimental Neurology,246, 72–83.
Burton, N. C., Kensler, T. W., & Guilarte, T. R. (2006). In vivo modulation of the Parkinsonian phenotype by Nrf2. Neurotoxicology,27(6), 1094–1100.
Cadenas, S., Rojas, C., Perez-Campo, R., Lopez-Torres, M., & Barja, G. (1995). Vitamin E protects guinea pig liver from lipid peroxidation without depressing levels of antioxidants. International Journal of Biochemistry & Cell Biology,27, 1175–1181.
Camara, A. K., Lesnefsky, E. J., & Stowe, D. F. (2010). Potential therapeutic benefits of strategies directed to mitochondria. Antioxidants & Redox Signal,13(3), 279–347.
Chance, B., & Williams, G. R. (1956). Respiratory enzymes in oxidative phosphorylation.VI. The effects of adenosine diphosphate on azide-treated mitochondria. The Journal of Biological Chemistry,221(1), 477–490.
Choi, H. J., Lee, S. Y., Cho, Y., No, H., Kim, S. W., & Hwang, O. (2006). Tetrahydrobiopterin causes mitochondrial dysfunction in dopaminergic cells: Implications for Parkinson's disease. Neurochemistry Inernational,48(4), 255–262.
Darbinyan, L. V., Hambardzumyan, L. E., Simonyan, K. V., Chavushyan, V. A., Manukyan, L. P., Badalyan, S. A., et al. (2017). Protective effects of curcumin against rotenone-induced rat model of Parkinson’s disease: In vivo electrophysiological and behavioral study. Metabolic Brain Disease,32(6), 1791–1803.
Deacon, R. M., Koros, E., Bornemann, K. D., & Rawlins, J. N. (2009). Aged Tg2576 mice are impaired on social memory and open field habituation tests. Behavioural Brain Research,197(2), 466–468.
Dexter, D. T., Sian, J., Rose, S., Hindmarsh, J. G., Mann, V. M., Cooper, J. M., et al. (1994). Indices of oxidative stress and mitochondrial function in individuals with incidental Lewy body disease. Annals of Neurology,35(1), 38–44.
Diederich, N. J., Moore, C. G., Leurgans, S. E., Chmura, T. A., & Goetz, C. G. (2003). Parkinson disease with old-age onset: A comparative study with subjects with middle-age onset. Archives of Neurology,60(4), 529–533.
Ferro, M. M., Bellissimo, M. I., Anselmo-Franci, J. A., Angellucci, M. E., Canteras, N. S., & Da Cunha, C. (2005). Comparison of bilaterally 6-OHDA-and MPTP-lesioned rats as models of the early phase of Parkinson's disease: histological, neurochemical, motor and memory alterations. Journal of Neuroscience Methods,148(1), 78–87.
Fu, M. H., Wu, C. W., Lee, Y. C., Hung, C. Y., Chen, I. C., & Wu, K. L. (2018). Nrf2 activation attenuates the early suppression of mitochondrial respiration due to the α-synuclein overexpression. Biomedical Journal,41(3), 169–183.
Garabadu, D., Shah, A., Ahmad, A., Joshi, V. B., Saxena, B., Palit, G., et al. (2011). Eugenol as an anti-stress agent: modulation of hypothalamic–pituitary–adrenal axis and brain monoaminergic systems in a rat model of stress. Stress,14(2), 145–155.
Geibl, F. F., Henrich, M. T., & Oertel, W. H. (2019). Mesencephalic and extramesencephalic dopaminergic systems in Parkinson’s disease. Journal of Neural Transmission (Vienna, Austria: 1996),126(4), 377–396.
Golechha, M., Chaudhry, U., Bhatia, J., Saluja, D., & Arya, D. S. (2011). Naringin protects against kainic acid-induced status epilepticus in rats: evidence for an antioxidant, anti-inflammatory and neuroprotective intervention. Biological & Pharmaceutical Bulletin,34(3), 360–365.
Gopinath, K., & Sudhandiran, G. (2012). Naringin modulates oxidative stress and inflammation in 3-nitropropionic acid-induced neurodegeneration through the activation of nuclear factor-erythroid 2-related factor-2 signalling pathway. Neuroscience,227, 134–143.
Gopinath, K., Prakash, D., & Sudhandiran, G. (2011). Neuroprotective effect of naringin, a dietary flavonoid against 3-nitropropionic acid-induced neuronal apoptosis. Neurochemistry Inernatinal,59(7), 1066–1073.
Griffiths, D. E., & Houghton, R. L. (1974). Studies on energy-linked reactions: Modified mitochondrial ATPase of oligomycin-resistant mutants of Saccharomyces cerevisiae. European Journal of Biochemistry,46(1), 157–167.
Hall, C. S. (1934). Emotional behavior in the rat. I. Defecation and urination as measures of individual differences in emotionality. Journal of Comparative Psychology,18(3), 385–403.
Henderson, J. M., Stanic, D., Tomas, D., Patch, J., Horne, M. K., Bourke, D., et al. (2005). Postural changes after lesions of the substantia nigra pars reticulata in hemiparkinsonian monkeys. Behavioural Brain Research,160(2), 267–276.
Huang, S. G. (2002). Development of a high throughput screening assay for mitochondrial membrane potential in living cells. Journal of Biomolecular Screening,7(4), 383–389.
Huang, H., Wu, K., You, Q., Huang, R., & Li, S. (2013). Naringin inhibits high glucose-induced cardiomyocyte apoptosis by attenuating mitochondrial dysfunction and modulating the activation of the p38 signaling pathway. International Journal of Molecular Medicine,32(2), 396–402.
Jagetia, G. C., & Reddy, T. K. (2002). The grapefruit flavanone naringin protects against the radiation-induced genomic instability in the mice bone marrow: A micronucleus study. Mutation Research,519(1–2), 37–48.
Jakel, R. J., Townsend, J. A., Kraft, A. D., & Johnson, J. A. (2007). Nrf2-mediated protection against 6-hydroxydopamine. Brain Research,1144, 192–201.
Jung, U. J., & Kim, S. R. (2014). Effects of naringin, a flavanone glycoside in grapefruits and citrus fruits, on the nigrostriatal dopaminergic projection in the adult brain. Neural Regeneration Research,9(16), 1514–1517.
Kamboj, S. S., Kumar, V., Kamboj, A., & Sandhir, R. (2008). Mitochondrial oxidative stress and dysfunction in rat brain induced by carbofuran exposure. Cellular & Molecular Neurobiology,28(7), 961–969.
Kim, C., Speisky, M. B., & Kharouba, S. N. (1987). Rapid and sensitive method for measuring norepinephrine, dopamine, 5-hydroxytryptamine and their major metabolites in rat brain by high-performance liquid chromatography. Differential effect of probenecid, haloperidol and yohimbine on the concentrations of biogenic amines and metabolites in various regions of rat brain. Journal of Chromatography,386, 25–35.
Kim, H. J., Song, J. Y., Park, H. J., Park, H. K., Yun, D. H., & Chung, J. H. (2009). Naringin protects against rotenone-induced apoptosis in human neuroblastoma SH-SY5Y cells. The Korean Journal of Physiology and Pharmacology,13(4), 281–285.
Kim, H. D., Jeong, K. H., Jung, U. J., & Kim, S. R. (2016). Naringin treatment induces neuroprotective effects in a mouse model of Parkinson's disease in vivo, but not enough to restore the lesioned dopaminergic system. The Journal of Nutritional Biochemistry,28, 140–146.
Klapdor, K., Dulfer, B. G., Hammann, A., & Van der Staay, F. J. (1997). A low-cost method to analyse footprint patterns. Journal of Neuroscience Methods,75, 49–54.
Leem, E., Nam, J. H., Jeon, M. T., Shin, W. H., Won, S. Y., Park, S. J., et al. (2014). Naringin protects the nigrostriatal dopaminergic projection through induction of GDNF in a neurotoxin model of Parkinson's disease. The Journal of Nutritional Biochemistry,25(7), 801–806.
Leung, K. W., Yung, K. K., Mak, N. K., Chan, Y. S., Fan, T. P., & Wong, R. N. (2007). Neuroprotective effects of ginsenoside-Rg1 in primary nigral neurons against rotenone toxicity. Neuropharmacology,52(3), 827–835.
Liu, D., Xiao, B., Han, F., Wang, E., & Shi, Y. (2012). Single-prolonged stress induces apoptosis in dorsal raphe nucleus in the rat model of post-traumatic stress disorder. BMC Psychiatry,12, 211.
Lowry, O. H., Rosebrough, N. J., Farr, A. L., & Randall, R. J. (1951). Protein measurement with the Folin phenol reagent. The Journal of Biological Chemistry,193(1), 265–275.
Madiha, S., Tabassum, S., Batool, Z., Liaquat, L., Sadir, S., Shahzad, S., et al. (2017). Assessment of gait dynamics in rotenone-induced rat model of Parkinson's disease by footprint method. Pakistan Journal of Pharmaceutical Sciences,30(3(Suppl.)), 943–948.
Medeiros-Linard, C. F., Andrade-da-Costa, B. L. D. S., Augusto, R. L., Sereniki, A., Trevisan, M. T. S., Perreira, R. C. R., et al. (2018). Anacardic acids from cashew nuts prevent behavioral changes and oxidative stress induced by rotenone in a rat model of Parkinson’s disease. Neurotoxicity Research,34(2), 250–262.
Middleton, E., Kandaswami, C., & Theoharides, T. C. (2000). The effects of plant flavonoids on mammalian cells: Implications for inflammation, heart disease, and cancer. Pharmacological Reviews,52(4), 673–751.
Moran, P. M., Higgins, L. S., Cordell, B., & Moser, P. C. (1995). Age-related learning deficits in transgenic mice expressing the 751-amino acid isoform of human beta-amyloid precursor protein. Proceedings of the National Academy of Sciences of the United States of America,92(12), 5341–5345.
Nakhate, K. T., Bharne, A. P., Verma, V. S., Aru, D. N., & Kokare, D. M. (2018). Plumbagin ameliorates memory dysfunction in streptozotocin induced Alzheimer’s disease via activation of Nrf2/ARE pathway and inhibition of β-secretase. Biomedicine & Pharmacothererapy,101, 379–390.
Olanow, C. W., Perl, D. P., DeMartino, G. N., & McNaught, K. S. (2004). Lewy-body formation is an aggresome-related process: A hypothesis. The Lancet. Neurology,3(8), 496–503.
Old, S. L., & Johnson, M. A. (1989). Methods of microphotometric assay of succinate dehydrogenase and cytochrome c oxidase activities for use on human skeletal muscle. The Histochemical Journal,21(9–10), 545–555.
Pari, L., & Amudha, K. (2011). Hepatoprotective role of naringin on nickel-induced toxicity in male Wistar rats. European Journal of Pharmacology,650(1), 364–370.
Paxinos, G., & Watson, C. (1998). The rat brain in stereotaxic coordinates (p. 4). San Diego. p: Acadamic Press.
Pedersen, P. L., Greenawalt, J. W., Reynafarje, B., Hullihen, J., Decker, G. L., Soper, J. W., et al. (1978). Preparation and characterization of mitochondria and sub-mitochondrial particles of rat liver-derived tissues. Methods in Cell Biology,20, 411–481.
Prajapati, S. K., Garabadu, D., & Krishnamurthy, S. (2017). Coenzyme Q10 prevents mitochondrial dysfunction and facilitates pharmacological activity of atorvastatin in 6-OHDA induced dopaminergic toxicity in rats. Neurotoxicity Research,31(4), 478–492.
Reddy, D. S., & Kulkarni, S. K. (1998). Possible role of nitric oxide in the nootropic and antiamnesic effects of neurosteroids on aging-and dizocilpine-induced learning impairment. Brain Research,799(2), 215–229.
Requejo-Aguilar, R., & Bolanos, J. P. (2016). Mitochondrial control of cell bioenergetics in Parkinson’s disease. Free Radical Biology & Medicine,100, 123–137.
Rojo, A. I., Innamorato, N. G., Martín-Moreno, A. M., De Ceballos, M. L., Yamamoto, M., & Cuadrado, A. (2010). Nrf2 regulates microglial dynamics and neuroinflammation in experimental Parkinson's disease. Glia,58(5), 588–598.
Rozas, G., Guerra, M. J., & Labandeira-Garcıa, J. L. (1997). An automated rotarod method for quantitative drug-free evaluation of overall motor deficits in rat models of parkinsonism. Brain Research. Brain Research Protocols,2(1), 75–84.
Savitt, J. M., Dawson, V. L., & Dawson, T. M. (2006). Diagnosis and treatment of Parkinson disease: Molecules to medicine. The Journal of Clinical Investigation,116(7), 1744–1754.
Schapira, A. H., Gu, M., Taanman, J. W., Tabrizi, S. J., Seaton, T., Cleeter, M., et al. (1998). Mitochondria in the etiology and pathogenesis of Parkinson's disease. Annals of Neurology,44(3 Suppl 1), S89–98.
Schulz, D., Mirrione, M. M., & Henn, F. A. (2010). Cognitive aspects of congenital learned helplessness and its reversal by the monoamine oxidase (MAO)-B inhibitor deprenyl. Neurobiology of Learning and Memory,93(2), 291–301.
Shapiro, B. L., Feigal, R. J., & Lam, L. F. (1979). Mitrochondrial NADH dehydrogenase in cystic fibrosis. Proceeding of the National Academy of sciences of the United States of America,76(6), 2979–2983.
Singh, D., Chander, V., & Chopra, K. (2004). Protective effect of naringin, a bioflavonoid on glycerol-induced acute renal failure in rat kidney. Toxicology,201(1–3), 143–151.
Storrie, B., & Madden, E. A. (1990). Isolation of subcellular organelles. Methods of Enzymology,182, 203–225.
Subaraja, M., & Vanisree, A. J. (2016). Rotenone causing dysfunctional mitochondria and lysosomes in cerebral ganglions of Lumbricus terrestris degenerate giant fibers and neuromuscular junctions. Chemosphere,152, 468–480.
Teerapattarakan, N., Benya-Aphikul, H., Tansawat, R., Wanakhachornkrai, O., Tantisira, M. H., & Rodsiri, R. (2018). Neuroprotective effect of a standardized extract of Centella asiatica ECa233 in rotenone-induced parkinsonism rats. Phytomedicine: International Journal of Phytotherapy and Phytopharmacology,44, 65–73.
Vauzour, D., Vafeiadou, K., Rodriguez-Mateos, A., Rendeiro, C., & Spencer, J. P. (2008). The neuroprotective potential of flavonoids: A multiplicity of effects. Genes & Nutrition,3(3–4), 115–126.
Wendel, A. (1981). Glutathione peroxidase. Methods of Enzymology,77, 325–333.
Xiong, N., Long, X., Xiong, J., Jia, M., Chen, C., Huang, J., et al. (2012). Mitochondrial complex I inhibitor rotenone-induced toxicity and its potential mechanisms in Parkinson’s disease models. Critical Reviews in Toxicology,42(7), 613–632.
Zhang, L., Hao, J., Zheng, Y., Su, R., Liao, Y., Gong, X., et al. (2018). Fucoidan protects dopaminergic neurons by enhancing the mitochondrial function in a rotenone-induced rat model of Parkinson’s disease. Aging and Disease,9(4), 590–604.
Acknowledgements
NA is thankful to GLA University, Mathura, Uttar Pradesh, India for the financial assistantship.
Author information
Authors and Affiliations
Corresponding author
Ethics declarations
Conflict of interest
The authors declare that they have no conflict of interests.
Additional information
Publisher's Note
Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.
Rights and permissions
About this article
Cite this article
Garabadu, D., Agrawal, N. Naringin Exhibits Neuroprotection Against Rotenone-Induced Neurotoxicity in Experimental Rodents. Neuromol Med 22, 314–330 (2020). https://doi.org/10.1007/s12017-019-08590-2
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s12017-019-08590-2